Post Profile
Watson’s $5.9B For Actavis Earning Applause as Shares Pop
Late Wednesday, Watson Pharmaceuticals made it official that it was buying Actavis for $5.9 billion, creating a giant in the generic drug market.
read more
Watson Said to Near $6.6 Billion Deal for Actavis
Watson Pharmaceuticals is expected to bid as much as €5 billion ($6.6 billion) for the Swiss drug maker Actavis Group, in a deal that would create one of the world's largest generic drug manufacturers. Read Post
Watson to Buy Actavis for $5.9 Billion
Watson Pharmaceuticals agreed on Wednesday to buy the Swiss drug maker Actavis Group for up to 4.5 billion euros ($5.9 billion), as the American company looked to expand its presence in overseas markets. Read Post
Watson Said to Bid $5.9 Billion for Actavis
Watson Pharmaceuticals is expected to offer 4.5 billion euros ($5.9 billion) for Swiss drug maker Actavis Group on Wednesday, in a deal that would create one of the world's largest generic drug manufacturers. Read Post